Lifeward (LFWD) EBIT (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.01% |
| Dec 31, 2025 | -62.99% |
| Sep 30, 2025 | 52.16% |
| Jun 30, 2025 | -35.24% |
| Mar 31, 2025 | 68.13% |
| Dec 31, 2024 | -379.77% |
| Sep 30, 2024 | 28.56% |
| Jun 30, 2024 | 31.67% |
| Mar 31, 2024 | -5.95% |
| Dec 31, 2023 | 22.73% |
| Sep 30, 2023 | -53.97% |
| Jun 30, 2023 | -17.90% |
| Mar 31, 2023 | 12.59% |
| Dec 31, 2022 | 7.88% |
| Sep 30, 2022 | -24.15% |
| Jun 30, 2022 | -2.05% |
| Mar 31, 2022 | -11.93% |
| Dec 31, 2021 | -43.91% |
| Sep 30, 2021 | 15.25% |
| Jun 30, 2021 | -3.97% |
| Mar 31, 2021 | -8.63% |
| Dec 31, 2020 | 9.38% |
| Sep 30, 2020 | -20.26% |
| Jun 30, 2020 | 29.15% |
| Mar 31, 2020 | -12.32% |
| Dec 31, 2019 | -5.81% |
| Sep 30, 2019 | 28.43% |
| Jun 30, 2019 | -18.46% |
| Mar 31, 2019 | -134.86% |
| Dec 31, 2018 | 348.73% |
| Sep 30, 2018 | 21.85% |
| Jun 30, 2018 | 9.69% |
| Mar 31, 2018 | -3.99% |
| Dec 31, 2017 | -4.97% |
| Sep 30, 2017 | 0.28% |
| Jun 30, 2017 | 5.09% |
| Mar 31, 2017 | 29.62% |
| Dec 31, 2016 | -8.54% |
| Sep 30, 2016 | 13.80% |
| Jun 30, 2016 | -33.87% |
| Mar 31, 2016 | 14.52% |
| Dec 31, 2015 | -19.03% |
| Sep 30, 2015 | -7.91% |
| Jun 30, 2015 | -5.83% |
| Mar 31, 2015 | -4.58% |
| Dec 31, 2014 | 32.25% |
| Dec 31, 2013 | -21.32% |